Camilla Hofström

Maryam Sahi¹, 

Sarah Andersson¹, 

Cecilia Mattson¹, 

Matilda Dale¹, 

Sofia Kagiolglou¹, 

Camilla Hofström², 

Helena Persson², 

Jonas Klingström^3,4, 

Francesca Chiodi⁵, 

Claudia Fredolini¹ 

¹Affinity Proteomics-Stockholm Unit, SciLifeLab, Division of Affinity Proteomics, Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health (CBH), KTH Royal Institute of Technology, 

²Human Antibody Therapeutics Unit, SciLifeLab, Division of Drug Discovery and Development, Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health (CBH), KTH Royal Institute of Technology, 

³Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, 

⁴, Public Health Agency of Sweden, 

⁵Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet